Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy
FEDERMAN D, HUSSAIN F, WALTERS J. Fatal Rhabdomyolysis Caused by Lipid-Lowering Therapy. Southern Medical Journal 2001, 94: 1023-1026. PMID: 11702815, DOI: 10.1097/00007611-200110000-00016.Peer-Reviewed Original ResearchMeSH KeywordsAgedDrug InteractionsFatal OutcomeGemfibrozilHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypercholesterolemiaHypolipidemic AgentsMaleRhabdomyolysisSimvastatinConceptsStatin therapyFatal rhabdomyolysisHigh-dose statin therapyDose statin therapySevere lipid abnormalitiesLipid-Lowering TherapyCoronary artery diseaseCombination of simvastatinTreatment of hypercholesterolemiaRenal insufficiencyLipid abnormalitiesArtery diseaseCombination therapyRisk factorsTherapyRhabdomyolysisAdditional agentsPatientsFibratesHypercholesterolemiaInsufficiencyMortalitySimvastatinAbnormalitiesClinicians